OBJECTIVE: To review systematically the clinical evidence on strategies to prevent and manage autonomic dysreflexia (AD). DATA SOURCES: A key word search of several databases (Medline, CINAHL, EMBASE, and PsycINFO), in addition to manual searches of retrieved articles, was undertaken to identify all English-language literature evaluating the efficacy of interventions for AD. STUDY SELECTION: Studies selected for review included randomized controlled trials (RCTs), prospective cohort studies, and cross-sectional studies. Treatments reviewed included pharmacologic and nonpharmacologic interventions for the management of AD in subjects with spinal cord injury. Studies that failed to assess AD outcomes (eg, blood pressure) or symptoms (eg, headaches, sweating) were excluded. DATA EXTRACTION: Studies were critically reviewed and assessed for their methodologic quality by 2 independent reviewers. DATA SYNTHESIS: Thirty-one studies were assessed, including 6 RCTs. Preventative strategies to reduce the episodes of AD caused by common triggers (eg, urogenital system, surgery) primarily were supported by level 4 (pre-post studies) and level 5 (observational studies) evidence. The initial acute nonpharmacologic management of an episode of AD (ie, positioning the patient upright, loosening tight clothing, eliminating any precipitating stimulus) is supported by clinical consensus and physiologic data (level 5 evidence). The use of antihypertensive drugs in the presence of sustained elevated blood pressure is supported by level 1 (prazosin) and level 2 evidence (nifedipine and prostaglandin E(2)). CONCLUSIONS: A variety of options are available to prevent AD (eg, surgical, pharmacologic) and manage the acute episode (elimination of triggers, pharmacologic); however, these options are predominantly supported by evidence from noncontrolled trials, and more rigorous trials are required.
OBJECTIVE: To review systematically the clinical evidence on strategies to prevent and manage autonomic dysreflexia (AD). DATA SOURCES: A key word search of several databases (Medline, CINAHL, EMBASE, and PsycINFO), in addition to manual searches of retrieved articles, was undertaken to identify all English-language literature evaluating the efficacy of interventions for AD. STUDY SELECTION: Studies selected for review included randomized controlled trials (RCTs), prospective cohort studies, and cross-sectional studies. Treatments reviewed included pharmacologic and nonpharmacologic interventions for the management of AD in subjects with spinal cord injury. Studies that failed to assess AD outcomes (eg, blood pressure) or symptoms (eg, headaches, sweating) were excluded. DATA EXTRACTION: Studies were critically reviewed and assessed for their methodologic quality by 2 independent reviewers. DATA SYNTHESIS: Thirty-one studies were assessed, including 6 RCTs. Preventative strategies to reduce the episodes of AD caused by common triggers (eg, urogenital system, surgery) primarily were supported by level 4 (pre-post studies) and level 5 (observational studies) evidence. The initial acute nonpharmacologic management of an episode of AD (ie, positioning the patient upright, loosening tight clothing, eliminating any precipitating stimulus) is supported by clinical consensus and physiologic data (level 5 evidence). The use of antihypertensive drugs in the presence of sustained elevated blood pressure is supported by level 1 (prazosin) and level 2 evidence (nifedipine and prostaglandin E(2)). CONCLUSIONS: A variety of options are available to prevent AD (eg, surgical, pharmacologic) and manage the acute episode (elimination of triggers, pharmacologic); however, these options are predominantly supported by evidence from noncontrolled trials, and more rigorous trials are required.
Authors: James W Grau; Rachel E Baine; Paris A Bean; Jacob A Davis; Gizelle N Fauss; Melissa K Henwood; Kelsey E Hudson; David T Johnston; Megan M Tarbet; Misty M Strain Journal: Exp Neurol Date: 2020-04-28 Impact factor: 5.330
Authors: Jill M Wecht; Joseph P Weir; Marinella Galea; Stephanie Martinez; William A Bauman Journal: Arch Phys Med Rehabil Date: 2015-02-04 Impact factor: 3.966
Authors: Alecsandra Araujo Paula; Renata Amadei Nicolau; Mario de Oliveira Lima; Miguel Angel Castillo Salgado; José Carlos Cogo Journal: Lasers Med Sci Date: 2014-05-24 Impact factor: 3.161
Authors: Jennifer L Collinger; Michael A Kryger; Richard Barbara; Timothy Betler; Kristen Bowsher; Elke H P Brown; Samuel T Clanton; Alan D Degenhart; Stephen T Foldes; Robert A Gaunt; Ferenc E Gyulai; Elizabeth A Harchick; Deborah Harrington; John B Helder; Timothy Hemmes; Matthew S Johannes; Kapil D Katyal; Geoffrey S F Ling; Angus J C McMorland; Karina Palko; Matthew P Para; Janet Scheuermann; Andrew B Schwartz; Elizabeth R Skidmore; Florian Solzbacher; Anita V Srikameswaran; Dennis P Swanson; Scott Swetz; Elizabeth C Tyler-Kabara; Meel Velliste; Wei Wang; Douglas J Weber; Brian Wodlinger; Michael L Boninger Journal: Clin Transl Sci Date: 2013-08-27 Impact factor: 4.689
Authors: Jill M Wecht; Christopher M Cirnigliaro; Frank Azarelo; William A Bauman; Steven C Kirshblum Journal: Clin Auton Res Date: 2015-04-28 Impact factor: 4.435